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Rapport de synthèse 
Titre: Un score clinique pour exclure une maladie coronarienne chez des patients 
présentant une douleur thoracique en médecine de premier recours 
La douleur thoracique est un motif de consultation fréquente (1-2%) en médecine de premier 
recours et peut être la manifestation d'une maladie coronarienne dont la prévalence est 
estimée à 12%, contrairement aux urgences où elle représente 50% des cas de douleurs 
thoraciques. La démarche diagnostique de la maladie coronarienne reste peu étudiée en 
médecine de premiers recours, contrairement aux services d'urgence où des guidelines ont 
déjà vu le jour. Le but de notre étude est de construire un modèle composé de variables 
cliniques facilement accessibles au cabinet dans le but d'évaluer la probabilité d'une maladie 
coronarienne chez les patients avec douleurs thoraciques. 
Nous avons effectué une analyse secondaire de données récoltées par l'étude prospective 
TOPIC (Toracic Pain in Community) réalisée auprès de 59 médecins généralistes en Suisse 
Romande avec l'inclusion de 672 patients présentant une douleur thoracique de mars à juin 
2001. Le diagnostic définitif étant posé après un suivi d'une année ( « delayed diagnosis ») et 
confirmé par un groupe d'experts avec vérification des données. Au total 85 patients ont eu un 
diagnostic de maladie coronarienne (angor stable, angor instable, infarctus myocarde). La 
validation externe a été faite avec les données de la cohorte de Marbourg, étude ayant inclus 
1199 patients auprès de 74 médecins généralistes avec un suivi de 6 mois. 
Par un modèle de régression logistique nous avons retenu au final 8 variables connues dans la 
littérature pour être en lien avec la maladie coronarienne et qui sont sorties statistiquement 
significatives dans notre étude. Il s'agit de l'âge-sexe, la présence de facteurs de risque 
cardiovasculaires la présence d'une maladie coronarienne dans le passé, et des 
caractéristiques de la douleur (durée 1-60 minutes, rétrosternales, liée à l'effort, non 
reproductible à la palpation). Notre score compte au total 11 points et la valeur prédictive 
montre une valeur ROC à 0.946 (0.924-0.968). 413 patients (62.5%) ont été classés dans le 
groupe à bas risque ( < 5 points) avec une prévalence de maladie coronarienne de 0.5% 
(2 /413), on ne compte pas de décès de maladie coronarienne dans ce groupe. Considérant ce 
seuil, la sensibilité du score est 97.6%, la spécificité de 71.3% et la valeur prédictive négative 
de 99.5% (411/413). 
La validation interne du modèle a montrée une bonne stabilité par la méthode de 
bootstrapping. La validation externe effectuée dans la cohorte allemande de Marburg a 
montré une valeur ROC de 0.752 (0.716-0.809). La prévalence de maladie coronarienne est de 
15% (15/289) dans le groupe à bas risque, la sensibilité de 85 .6%, la spécificité de 4 7 .2%, et 
la valeur prédictive négative 94.8%. 
Jusqu'à ce jour, la littérature ne mentionne pas de score clinique développé au cabinet du 
médecin de premier recours concernant l'évaluation de la probabilité de maladie coronarienne 
chez les patients avec douleurs thoraciques, bien que la présentation soit différente des 
urgences. Dans cette étude nous avons construit un score basé uniquement sur l'anamnèse et 
l'examen clinique qui permet de classer deux tiers des patients dans un faible risque de 
maladie coronarienne avec une forte valeur prédictive négative (99.5% dans la cohorte de 
dérivation et de 94.8% dans la cohorte de validation). Néanmoins ce score n'est pas à elle 
seule suffisante pour exclure une maladie coronarienne (0.5% de maladie coronarienne dans 
le groupe à bas risque dans la cohorte de dérivation et 5.2% dans la cohorte de validation). Ce 
score peut être un outil intéressant pour le généraliste dans la prise en charge de patients avec 
douleurs thoraciques. D'autres études sont nécessaires pour la suite, afin d'évaluer 
l'application de ce score dans la pratique courante. 
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Abstract 
Background: Chest pain raises concern for the possibility of coronary heart disease. Scoring methods have been 
developed to identify coronary heart disease in emergency settings, but not in primary care. 
Methods: Data were collected from a multicenter Swiss clinical cohort study including 672 consecutive patients 
with chest pain, who had visited one of 59 family practitioners' offices. Using delayed diagnosis we derived a 
prediction rule to rule out coronary heart disease by means of a logistic regression model. Known cardiovascular 
1 risk factors, pain characteristics, and physical signs associated with coronary heart disease were explored to develop ' 
a clinical score. Patients diagnosed with angina or acute myocardial infarction within the year following their initial 
visit comprised the coronary heart disease group. 
Results: The coronary heart disease score was derived from eight variables: age, gender, duration of chest pain 
from 1 to 60 minutes, substernal chest pain location, pain increasing with exertion, absence of tenderness point at 
palpation, cardiovascular risks factors, and persona! history of cardiovascular disease. Area under the receiver 
operating characteristics curve was of 0.95 with a 95% confidence interval of 0.92; 0.97. From this score, 413 
patients were considered as low risk for values of percentile 5 of the coronary heart disease patients. Internai 
validity was confirmed by bootstrapping. External validation using data from a German cohort (Marburg, n = 774) 
' revealed a receiver operating characteristics curve of 0.75 (95% confidence interval, 0.72; 0.81) with a sensitivity of 
85.6% and a specificity of 47.2%. 
' Conclusions: This score, based only on history and physical examination, is a complementary tool for ruling out 
coronary heart disease in primary care patients complaining of chest pain. 
Background 
Chest pain is a common complaint that occurs in 1 to 
2% of primary care patients [l]. Chest pain raises con-
cerns about the occurrence of a serious condition such 
as coronary heart disease (CHO) [2], which is present in 
about 12% of primary care patients with chest pain 
[1.3]. Family practitioners should be equipped to rule 
out an acute CHO related event rapidly. They are used 
to estimating the probability of CHO in a patient with 
chest pain on the basis of pain characteristics, patient's 
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age, gender, history and cardiovascular risk factors [4]. 
Cardiovascular risk factors and chest pain history are 
associated with CHO, and have been widely studied 
[4,5]. However, chest pain characteristics alone are not 
sufficient to reliably rule out ischemic heart disease [6]. 
A more complete set of predictors is thus needed for 
this purpose. 
Predictive scores for CHO in emergency settings have 
been developed [7-9], and are now implemented [10,11]. 
However, these scores are not necessarily useful in the 
primary care setting [ 12]. To our knowledge, no ambu-
latory CHO score has been developed to support pri-
mary care physicians in ruling out CHO in patients with 
chest pain. Such a score might help physicians, reassure 
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patients [13], and spare tirne and resources from being 
spent on further investigations. The objective of this 
study was to develop an arnbulatory CHD predictive 
score, based only on the patient's history and physical 
exarnination in the prirnary care setting, to rule out 
CHD without further investigations of patients with 
ch.est-pain. 
Methods 
Design overview 
We used data from a rnulticenter clinicat cohort of pri-
rnary care patients with chest pain (TOPIC - Thoracic 
Pain in Cornmunity) [3] to develop a clinicat prediction 
score for CHD, and secondarily the data from a study 
conducted in Germany (Marburg study) to validate the 
score [14]. The primary goal of both these studies was 
to examine the frequency of occurrence, mode of pre-
sentation, etiology, clinical characteristics and correlates, 
management strategies and outcornes in these patients. 
Settings and participants 
The initial survey used a research network of family 
practitioners. Fifty-eight independent offices, urban and 
rural, and one primary care outpatient clinic from Wes-
tern Switzerland recruited patients from March to June 
2001. Farnily practitioners consecutively enrolled ail 
patients over 16 years of age who reported any type of 
ch.est pain during their visits (n = 672). The presence of 
ch.est pain was ascertained according to the usual prac-
tice of each family practitioner. Ch.est pain due to 
obvious causes such as trauma or known body metas-
tases were also included. Patients with anginal equiva-
lents alone, such as jaw pain, dyspnea on exertion, arm 
pain, and so on, were therefore excluded. Ch.est pain 
was not necessarily the chief complaint on presentation. 
Participating physicians had an average term of experi-
ence in private practice of 12 years (range 1 to 24). 
They received detailed information on the study and 
were trained to fil! in the forms during a special meet-
ing. Each patient gave informed consent to participate 
in the study. The study protocol was approved by the 
official state local Ethical Committee (Prot. 41/2000). 
Data collection 
Physicians completed the first part of the Case Report 
Form (CRF) during the patient's index visit. Additional 
follow-up information was obtained after three and 
twelve rnonths (additional encounters). Ail completed 
forms were sent to the study coordination center. A set 
of predefined criteria was used for data entry checks. 
The data entry clerk reported inconsistencies to the 
principle investigators, who contacted physicians when 
needed for case resolution. Missing data were completed 
by contacting physicians by telephone and obtaining 
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answers from the patient's record. Double data entry 
was used to identify transcription errors. Data cleaning 
and validation was performed by a group of physicians 
experienced in research. When the diagnosis reported 
by the farnily practitioner was not consistent throughout 
the year of follow-up, the final diagnosis for ch.est pain 
was discussed and approved by a group of clinicians 
who were not aware of the aim of this study. 
Predictive factors 
We recorded general patients' information as well as 
type, characteristics and location of ch.est pain. Ch.est 
pain was either already known or a new symptom. An 
initial plausible etiology, or early diagnosis, was noted. 
The first part of the CRF included 70 questions on his-
tory and clinicat signs of ch.est pain, of which 12 ques-
tions concerned factors that were known to be 
associated with CHD [ 6], and four concerned factors 
that were known to be unrelated to CHD (Table 1). 
These 16 factors of interest were chosen before any ana-
lysis as potential predictors of CHD. Ail variables, 
except age, were dichotomized, using the usually 
described eut-off points [6]. Having a cardiovascular risk 
was defined as having at least one known risk factor 
(that is, hypertension, hyperlipidemia, diabetes mellitus, 
smoking, family history of cardiovascular disease 
(CVD)). Our study th.en focused on either known pain 
characteristics related to CHD, or clinicat signs exclud-
ing CHD. The studied predictors are given in Table 1. 
Outcomes and follow-up 
In a prirnary care setting, it is very difficult to have ail 
patients' cardiovascular status assessed using a gold 
standard. W e therefore opted to use a delayed diagnosis 
over one year to detect patients with CHD. During the 
initial visit, the suspected diagnosis was noted and th.en 
confirmed or modified during follow-up. Detailed infor-
mation on patients' history and physical examination, 
level of anxiety expressed by patients and physicians, 
cardiovascular and thrombo-embolic risk factors, labora-
tory results obtained in emergencies, co-morbidities, 
medications, and treatment decisions at the end of the 
consultation were also collected. CRFs included infor-
mation on further examinations and laboratory assays, 
referrals to specialists, admissions to emergency wards, 
hospitalizations, and health events during the follow-up 
period. The diagnoses retained after 12 months of fol-
low-up were grouped in six categories: ch.est wall, CHD, 
psychogenic, respiratory, digestive, and miscellaneous. 
CHD included angina pectoris, unstable angina, and 
myocardial infarction (MI). Wh.en the diagnosis of ch.est 
pain was inconsistent or uncertain through the follow-
up, a group of investigators discussed the case. Wh.en 
the group of investigators was unable to confirm the 
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Table 1 Distribution of analyzed variables according to diagnostic group and unadjusted Odds Ratio over the 
derivation cohort. 
Variables Validation Derivation 
cohort cohort 
(n = 774) Ali (n = 661) CHD group (n = 85) Non-CHD group (n = OR(unddJustedl (95% 
576) Cl) 
% % n (°'o) n (%) 
Gender (Male) 42.0% 47.5% 43 (506%1 271 (470%1 1 2 (O 7 to 1 81 
Age-gender categories 
M < 5 5 yr or F < 65 yr 484% 57.8% 6(71%) 3 76 (65 3001 
M 55 to 64 yr or F 65 to 74 yr 260% 141% 17 (200%) 83 (144%1 12.8 (49 to 33 5) 
M 2 65 yr or F 2 75 yr 256% 27.1% 62 (729%1 117 (203%1 33.2 (140 to 78 71 
Known CVR 
None 21 2% 34.5% 2 (23%1 226 (39 2%1 
1 -2 532% 50.5% 46 (541%1 288 (500%1 181 (43 to 1581 
23 256% 150% 37 (435%1 62 (108%) 674 (15.8 to 28761 
Previous history of CVD 220% 18.2% 62 (729%1 58(101%1 24.1 (125 to 464) 
Characteristic of the pain 
Duration 1 to 60 minutes 42.6% 35.2% 66 (77 6%) 167 (290%1 85 (4 8 to 1 5 1) 
lncreasing on exertion 19.8% 21.3% 37 (43.5%) 104 (18 \%) 3 5 (2 1 to 5 7) 
Substernal area pain 57 5% 163% 43 (506%) 65 (\ 1 3%) 8.0 (47 to 1 3 7) 
No tenderness on palpation 570% 543% 74 (87.1%1 285 (49 5%1 6.9 (3 5 to 1 3 51 
Sudden excruciat1ng pain n/a 50.1% 34 (40.0%1 297 (51 6%) 0.63 (039 to 1 0) 
Oppressive pain 434% 36.5% 56 (65.9%) 185 (321%1 4 1 (2.5 to 67) 
Irradiation 140% 9.1% 8 (94%1 52 (90%1 1 .0 (OS to 23) 
Not position dependant n/a 75 8% 77 (90.6%) 424 (73 6%) 35(16to74) 
Not increased w1th breath1ng 782% 76.5% 80 (941%) 426 (740%) 5.6 (2 2 to 14 4) 
Digestive symptoms 29.0% 24 (28 2%) 168 (29 2%1 0 96 (0.58 to 1 61 
Context 
Known patient 913% 911% 80 (94 1%1 522 (906%1 1 7 (064 to 43) 
New complaint n/a 48.8% 19/83 (229%1 295/561 (52 6%1 027 (OIS to 0461 
Emergency n/a 29.1% 19 (223%1 173/574 (30 1%1 0.67 (039 to 1 11 
Principle cornplaint 89 3% 52.8% 42/84 (50.0%) 305/573 (53 2%) 0.88 (0 56 to 1 4) 
CVR status unknown (no labl n/3 4.8% 2 (2 3%1 30 (5 2%1 O 44 (O 1 to 1 91 
CHD = coronary heart disease; CVD = cardiovascular disease; CYR= cardiovascular risk; OR = odds ratio 
diagnosis, or if the diagnosis at 12 months was missing, 
the patient was contacted for further information 
through his family practitioner. If the patient could not 
be contacted, the diagnosis at three months was 
retained. Ten percent of all CRFs were revised by the 
group of investigators in evaluating the consistency of 
the final diagnosis. 
External validity 
months by experts who were blinded to patients' clinical 
conditions. Variables used from this study were age, sex, 
cardiovascular risk, history of CVO, presence of retroster-
nal chest pain, pain triggered by exertion, and pain at pal-
pation. Having a cardiovascular risk was defined as having 
at least one of the following characteristics: family history 
of CVO, diabetes, hypertension or treated hypertension, 
hyperlipidemia or treated hyperlipidemia, smoking orobe-
sity (Body Mass Index 230). 
External validity was clone using data from a German 
(Marburg) study. Briefly, 1,199 patients aged 35 and over 
with chest pain observed in one of 74 family practitioners' 
offices in Germany were successively included in this 
study. Chest pain was previously unknown and present for 
a maximum of one month. Patients were followed-up dur-
ing six months. Cases were defined as patients having 
been diagnosed with CHO during the following six 
Statistical analysis 
From previous studies we expected a prevalence of CHO 
of 10%. The study was powered to detect factors for 
which the risk of CHD was increased by two (20% vs. 
10%) with ~ set at 0.2 and a at 0.05. The smallest 
expected exposure group was the one including patients 
with previous history of CVO (20%). This required 
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including 127 patients with history of CYD and 510 
without, or a total of 637 patients with chest pain. 
Expecting 10% lost to follow-up or missing data, we 
rounded this to 700 patients. Bivariate analyses were 
performed to identify factors associated with CHO in 
patients with chest pain. Fishers' exact test was used. 
Variables associated with CHD (P < 0.1) were eligible 
for inclusion in a multivariable logistic mode!. A variable 
was retained in the mode! if it significantly contributed 
to the mode! (P < 0.05). Goodness of fit was assessed by 
means of the Hosmer and Lemshow test. A score was 
then defined on the basis of the coefficients of the logis-
tic regression, and rounded to the nearest unit. Area 
under the receiver operating characteristic (ROC) curve 
was an indicator of the discriminatory power of the 
score. The coefficient of the logistic mode! with CHD as 
the dependent variable and the score as the unique 
independent variable was estimated as a second perfor-
mance index [ 15]. Risk categories were defined on the 
basis of two eut off values of the score: percentile 5 of 
the CHD group for the low-risk category, and percentile 
95 of the non-CHO group for the high-risk category. 
Patients with a score between these two eut-off values 
were considered at intermediate-risk. The sensitivity and 
specificity of the prediction rule for discriminating low-
from intermediate- or high-risk cases indicated the clas-
sification performance of the score. The prevalence of 
CHO at given score levels and risk categories was deter-
mined, and the mean of the estimated individual prob-
abilities was given. Sensibility analysis was performed to 
assess the effect of not considering patients with 
unknown cardiovascular risk status to be at risk. Data 
were reanalyzed, considering patients with unknown 
cardiovascular risk status as patients having a risk. 
Internai validity was assessed by means of bootstrap-
ping techniques [ 16]. The whole analysis was replicated 
on 300 different samples of the same size drawn with 
replacement from the original sample. Following the 
same algorithm, new scores and new prediction rules 
(based on new eut off values) were defined and applied 
to the original sample and also to the bootstrapping 
sample. The area under the ROC curve was computed, 
as well as the calibration index and the sensitivity and 
specificity of the rule to classify low risk patients. The 
mean and standard deviation (SD) of the areas under 
the curves of the 300 scores, applied to the bootstrap 
samples and to the original sample, mean and standard 
deviation of the calibration index, applied to the boot-
strap sample and to the original sample, and the mean 
and SD of the sensibilities and specificities of the 300 
rules applied to the original sample were obtained. The 
mean number of times that patients, originally classified 
as low-risk, were reclassified in the low-risk category, 
and then the mean and S D of the predicted values were 
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computed for each patient. Finally, the mean of the 
mean and SD of the predicted values were given for 
each score level and risk category. 
For externat validation, the area under the ROC curve, 
sensitivity, specificity, negative likelihood ratio and 
occurrence of CHD in each risk group were calculated 
from the data available from the Marburg Study (14]. 
Only patients with complete data were included in ana-
lysis. Ail calculations were performed with StataCorp. 
2008, Statistical Software: Release 10.0., Stata Corpora-
tion, College Station, Texas, USA. 
Results 
Altogether, 672 patients were included in the study. 
Twenty-seven patients were lost to follow-up at one year. 
Their CHD status reported at three months was therefore 
carried forward and these patients were included in the 
analysis. Excluded patients were those having missing 
data on baseline cardiovascular risk status (n = 6) or 
were younger than 16 (n = 5). In the remaining group of 
661 patients, an average of 11.2 (SD, ±7.6) patients were 
recruited in each of the 59 centers. The total practice-
year we followed was of 4.8 years including Thursdays, 
Saturdays and Sundays when practices are closed. This 
corresponds to an average of 0.7 patients with chest pain 
for every GP for every working day. The recruitment per-
iod was nevertheless not the same between physicians. 
Eleven physicians stopped recruiting before they were 
meant to. If we overview the intervals from which 
patients were recruited for each physicians, inclusion was 
constant over time. Physicians apparently either stopped 
recruiting or continued recruiting per protocol. The 
mean age of patients included in analysis was 55.4 years 
(SD ±19), and 314 patients (47.5%) were male. Most 
patients (602, 91.1 %) were already known to their family 
practitioners, and 314 (47.5%) had never experienced the 
same type of pain before. One hundred and twenty 
patients (18.2%) had previous evidence of CHO or CVD 
(revascularization procedures, heart failure, or peripheral 
arterial disease) and 433 patients (65.5%) were known to 
have one or more cardiovascular risk factors, 196 were 
known to have none. The presence of cardio-vascular 
risk was unknown to the physician for 32 of the 661 
patients. Eighty-five patients (12.9%) were diagnosed with 
CHO, including 75 cases of angina pectoris (11.1%), six 
cases of unstable angina (0.9%) and four cases of myocar-
dial infarction (0.6%). None of the 196 patients for which 
it was known that they had no risk factor, and two of the 
32 patients with unlmown laboratory status were diag-
nosed with CHO. 
Building the prediction score 
Bivariate analyses identified 11 variables associated with 
CHO at a significance level of P = 0.1 (Table 1). The 
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variables were gender, known cardiovascular risk, past 
history of CVD, substernal pain location, duration of 
pain, pain during exertion, absence of tenderness, 
oppressive pain, sudden excruciating pain, pain depen-
dent of the position, pain increased by a deep breath 
and previously having felt the same pain. Not knowing 
if patients had dyslipidemia or diabetes (n = 32) was not 
associated to having CHD (Odds Ratio = 0.44; CI 95% 
0.1 to 1. 9). 
Age and gender were combined in a single ordinal vari-
able; men <55 and women <65 made the reference 
group. Men from 55 years to 64 years and women from 
65 years to 74 years were coded l, and men 65 years or 
over and women 75 years or over were coded 2. Pre-
viously having a similar complaint was confounded by 
other factors (0 = 0.59; P = 0.131). Including al! 661 
patients in the regression mode!, the following variables 
were not significant at a P = 0.05 level: previously having 
a similar complaint (0 = 0.35; P = 0.509), not position 
dependent (p = 0.35; P = 0.509), sudden excruciating 
pain (p = -0.49; P = 0.159), oppressive pain (p = 0.65; P = 
0.070), and not increased by a deep breath (0 = 1.3; P = 
0.059). These variables were excluded, and the coefficient 
of regression was computed for the seven remaining pre-
dictors (Table 2). Goodness-of-fit test of the model 
showed a good fit between expected and observed fre-
quencies of covariate patterns (P = 0.250). The absence 
of any clustering effect for physicians was confirmed 
using random-effects logistic regression (p = 0.0112; P = 
0.336). Adjusting for clustering had no effect on CHD 
score values. Only two cases were not identified at three 
months and were reported as such during the follow-up 
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period. Results of the logistic regression excluding these 
two cases remain the same. 
The regression coefficients, OR (adjusted and unad-
justed) are given in Table 2, as well as the contribution 
of each factor to the CHD score. The score ranged from 
0 to 11. The mode! allowed two points each for the fol-
lowing determinates: having a known cardiovascular 
risk, men over 55 years or women over 65 years, perso-
na! history of CVD, and substernal pain. The other 
determinants, duration, exertion with effort, and tender-
ness, each received one point. 
The area under the curve (AUC) of the receiver oper-
ating characteristics (ROC) (Figure 1) was 0.946 (95% 
CI, 0.924 to 0.968). The mode! showed a good overall 
performance (R2 = 0.538). The eut-off point for low-risk 
(defined as the fifth percentile of the CHD patients) was 
5. Thus, the 413 (62.5%) patients with scores <5 were 
defined as low-risk. In the low-risk group, one patient 
was diagnosed with stable angina and another with 
myocardial infarction during the following 12 months. 
The sensitivity of this rule is 97.6% (83/85), the specifi-
city 71.3% ( 411/576), the negative likelihood ratio of 
0.033, and the negative predictive value of 99.5% (411/ 
413). 
The eut off point for high-risk (defined as the 95th 
percentile of the non-CHD group) was 7. According to 
this rule, 87 patients (13.2%) with scores >7 were 
defined as being at high-risk. Finally, 161 patients 
(24.4%) were classified as intermediate-risk The preva-
lence of CHD in the low-risk category was 0.5% (2/413), 
12.4% (20/161) in the moderate category and 72.4% (63/ 
87) in the high-risk category (Table 3). 
Table 2 Regression coefficients, contributions to the CHO-score, ORs {adjusted) for the subpopulation with 
cardiovascular risks {n = 435). 
Variables Regression Coefficient 
Age-sex categories 
lv\ < 5 5 yr or F < 65 yr 
lv\ 55-64 yr or F 65 to 74 yr 
lv\ ;,, 65 yr or F ;,, 75 yr 
Known cardiovascular risk 
None 
1 to 2 
~3 
Known previous history of CVD 
Duration of chest pain 1 ta 60 minutes 
Area of pain described as substernal 
Precipitating with exertion 
Absence of tenderness 
• Adjusted for variables shown in this table. 
CHD = coronary heart disease; CVD = cardio-vascular disease; OR = odds ratio; 
ORadj = adjusted odds ratio 
0 
199 
244 
0 
1 7ô 
1 91 
1 89 
1 09 
1 65 
0 75 
1.22 
Score ORadjusted • 
OR,di (95% Cl) 
0 1 (reference) 
2 7 3 (24 to 225) 
115(4.2to31Si 
0 1 (reference) 
2 58 (1.2 [0 290) 
2 6.7 (IJ [0 352) 
2 67(32to138) 
3 O (1 4 to 6.2) 
5 2 (2 5 [O 10 9) 
2 1 (10 to 43) 
3 4 ( 15 to 80) 
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Figure 1 Receiver operating characteristics curve for the Ambulatory CHD score in both derivation and validation cohorts 
Classification of major events and electrocardiograms 
(ECG) 
Table 3 shows the prevalence of major events for each 
risk class. We observed one patient with acute myocar-
dial infarction classifted as low-risk. This patient's cardi-
ovascular risk status was unknown. During the year of 
follow-up, 24 patients died. Four of them belonged to 
the low-risk group. None of these patients were diag-
nosed with a CHD. lt is worth mentioning that 72 
ECGs were taken of low-risk patients, representing 
50.3% of ail the ECGs clone on patients with chest pain. 
For high-risk patients, less than one third were investi-
gated by ECG. 
Internai validity 
The results of the 300 iterations of score development 
(bootstrapping) gave consistent results with the initial 
analysis, except for 40 samples. The mean area under 
the curve for the 300 different prediction rules applied 
to the original sample was 0.942 (SD 0.004), and the 
mean calibration index was 0.87 (SD 0.13). When the 
predictive rules where applied to the bootstrap samples, 
we had a mean area under the curve of 0.950 (SD 
0.011), and a mean calibration index of 0.97 (SD 0.07). 
The difference between bath calibration indexes 
revealed the over-optimism of the mode!. The dispersion 
of the calibration index revealed some kind of instability 
of the mode! (due to the very small number of CHD in 
the group without known risk factor). Mean sensitivity 
and specificity for the rule-out threshold values were 
0.956 (SD 0.027) and 0.710 (SD 0.077), respectively. 
N evertheless, the classification appears to be relatively 
stable because the 392 patients in the low-risk category 
were classified on average 283.35 times (range 149 to 
300) in the low-risk category by the bootstrap rules. The 
mean prevalence of CHD in the low-risk category was 
0.005 (SD 0.005). The distribution of the prevalence of 
CHD by risk category is given in Table 3 where the 
score distribution is compared with the actual preva-
lence. The mean predicted values and mean deviation 
from original predicted values are given by risk category. 
External validity 
Data from the Marburg study were made available for 
validation [14]. From the data collected from 1,199 suc-
cessive patients with chest pain attending 74 general 
practitioners full data were available for 774 patients 
that were included in the analysis. Prevalence of CHD 
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Table 3 Prevalence of events for each level of risk, 
Events Low-risk CHO 
Score = 0-4 
n = 413 
n % (Cl 95%) 
Coronary Heart Disease 
Observed 0.5% (00 to 1 7) 
Prevalence from bootstrapp1ng• 0 7 (06) 
Validation cohort (N = 774) t 15/289 5.2% (30 to 8.4) 
Acute myocardial infarction 1 02% (O tolJ) 
Unstable angina 0 0% (O to 09) 
Oeaths 
Overall 4 1.0% (0 3 to 25) 
CVD 0 0% (0 to 09) 
CHD 0 0% (0 to 09) 
Mean and SD of predicted values according to the risk category (bootstrapping). 
n 
20 
40/327 
11 
2 
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lntermediate-risk High-risk 
CHO Score= 5-7 CHO Score= 8-11 
n = 161 n = 87 
% (Cl 95%) n % (Cl 95%) 
12.4% (78 to 18 5) 63 72.4'6 (618to815) 
14.6 (10) 69.4 (16) 
12.2% (89 to 163) 59/158 37.3% (298 to 45.4) 
0.6% (O to 3.4) 2 2.3% (03 to 81) 
1.2% (0 2 to 4.4) 4 46% (IJ to 11.4) 
6.8% (35 to 119) 9 10.3% (48 to 187) 
12% (02 to 4.4) 9 10.3% (48 to 87) 
1.2% (O 2 to 4.4) 80% (33 to 15 9) 
• Mean prevalence in each risk category (with SD) given by the 300 bootstrap rules (%) 
t Data drawn from the German cohort (Marburg study) 
CHD = coronary heart disease; CVD = cardio-vascular disease 
was similar (P = 0.254) between patients included in 
analysis (14.7%) and those who were excluded for miss-
ing data (12,3%), The area under the curve was of 0.752 
(95% CI 0,716; 0.809). Prevalence of CHD in the low 
risk category (score <5) was of 5.2% (Table 3). The rul-
ing out of CHD using the CHD-Score has a sensitivity 
of 85.6% and a specificity of 47,2%. Negative likelihood 
ratio was of 0.305 and negative predictive value of 
94.8%. The prevalence of CHD for each score value is 
given in Figure 2. Among the 15 patients with CHD in 
the low risk group, one had acute myocardial infarction 
and one had unstable angina. 
Discussion 
We developed a clinicat prediction score for ruling out 
CHD in primary care patients with chest pain. Our 
CHD score includes eight predictors (age, gender, hav-
ing at least one CVD risk factor, history of CVD, dura-
tion of pain, substernal location of pain, increased pain 
with exertion, absence of tenderness at palpation), 
which are al! known to be associated with CHD [6), and 
easily identifiable from history and physical examination. 
Our score can classify patients in three groups with an 
increasing prevalence of CHD, Bootstrapping, the 
recommended tool for this kind of modeling [15], was 
used to test interna! validity. Our ambulatory CHO 
score is consistent throughout our data, and the predic-
tive power of the mode! is acceptable. Our ruling-out 
score classified two thirds of the studied population in 
the low-risk category with a strong negative predictive 
value (99.8%). Negative predictive value remained high 
in the validation cohort (94.8%) with a negative likeli-
hood ratio of 0.31. Our ambulatory CHD score seems 
adapted for the management of CHDs in primary care. 
However, this score does not entirely rule out CHD as 
5.2% of patients in the low risk group from the valida-
tion cohort ended up having CHD within the next six 
months, 
Our data show bath sirnilarities and differences from 
the published determinants used to rule out CHD. The 
American College of Physicians [ 4] developed guidelines 
to manage patients in primary care for whom chronic 
stable angina was suspected, Our scores are in agree-
ment with their recommendations of using age, gender, 
cardiovascular risk factors, and pain characteristics to 
estimate the probability of CHD. Like the Framingham 
risk score [5], our ambulatory CHD score also includes 
age, gender, and cardiovascular risks as indicators of 
CHD events. The Framingham risk score does not 
include a persona! history of CVD or characteristics of 
pain, which are essential to detecting patients with 
CHD, These characteristics have been included in scores 
developed in emergency departments [7,8,17-25]. How-
ever, the prevalence and etiology of CHD differ consid-
erably between these two settings. CHO is about four 
times less frequent in patients with chest pain in pri-
mary care [l] than in those admitted in emergency 
departments [26]. Furthermore, the severity of CHO dif-
fers between these settings. Over 10% of patients hospi-
talized with chest pain [26,27] have a myocardial 
infarction, whereas we observed a prevalence of only 
0.6% in primary care [3]. Factors that may appear to be 
important or unimportant in samples with relatively few 
outcome events may be substantially misleading. For 
example, pain lasting for more than 60 minutes is very 
atypical for angina but not so unusual for an acute 
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Figure 2 Observed prevalence of CHO in both derivation and validation cohorts for each ambulatory CHO score value. 
myocardial infarction. Given the very low prevalence of 
myocardial infarction in this manuscript, factors that 
may be very important for diagnosing acute myocardial 
infarction may be substantially undervalued. This could 
explain why the area under the curve for predicting 
CHD seems better in our score than for either the 
TlMI, the PURSUIT or the GRACE scores (28]. This 
difference illustrates the importance of developing 
guidelines and scores specifically for the primary care 
setting instead of a mere use of scores developed for 
emergency department patients. 
The major strength of our study is the development of 
a clinical tool for family practitioners, using data col-
lected by a research network in primary care (29]. The 
use of the ambulatory CHD score, based only on the 
patient's history and physical examination, allows farnily 
practitioners to estimate risks of discharging a patient 
without further examinations. 
Our study has some limitations. W e would first like to 
remind physicians that scores derived from logistic 
regression cannot identify unusual presentations. Con-
sider the example of a young patient who abuses 
cocaine, and presenting an acute myocardial infarction. 
This patient wou\d be classified in the low-risk group 
(30]. Clinicat knowledge and experience therefore still 
remain essential in ruling out CHD in patients with 
chest pain [31,32]. Secondly, we used delayed diagnosis 
instead of referring ail patients to a specialist. Logistical 
resources and patients' unavailability make it very 
difficult to assure objective confirmation in prirnary care 
research. Furthermore, in the derivation cohort, asses-
sors were not blinded to the initial state of exposure 
when defining cases. However, 28% of the patients have 
been referred to s pecialists or to hospitals, and the one-
year follow up allows us to reasonably confirm the 
absence of missed CHD. Furthermore, in cases of doubt, 
the family practitioner was questioned for further infor-
mation. In the 10% of records reviewed by experts, only 
one controversial case was detected and resolved after 
discussion with the farnily practitioner. We therefore 
believe that misclassification is negligible. lt should be 
noted that most patients were known to their primary 
care physicians, a factor that could have facilitated the 
diagnostic process. Physicians were therefore not 
blinded to their patient's condition and could have been 
more likely to report some signs knowing their patient 
had cardiac chest pain. Furthermore, we cannot exclude 
that patients with Ml or unstable angina which rapidly 
became entirely asymptomatic remained undetected. 
The study is also underpowered to detect any difference 
in myocardial infarction or unstable angina between the 
risk groups. Finally, externat validation showed the score 
to be much less sensitive than it was meant to be. Bath 
studies however included different patients. ln the Mar-
burg study, young patients were not included (<-:35 years 
vs. <-:16 years), nor were those with posterior chest pain 
or pain lasting more than one month. The Marburg 
study therefore excluded patients who were more likely 
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to be at low risk compared to those included in the Lau-
sanne cohort. This method nevertheless shows a better 
diagnosis ability than recognized laboratory markers 
such as BNP and NT-proBNP [33] in possible heart fail-
ure patients. 
Conclusions 
In summary, we developed a clinicat prediction score to 
rule out CHD in primary care patients with chest pain. 
This clinical tool may limit clinicat investigation in 
patients with chest pain in primary care where the pre-
sentation and the management are completely different 
from the er:nergency departments. However, further ana-
lyses of the proposed score should be conducted in var-
ious primary care contexts to evaluate its true benefit 
better and evaluate its implementation. 
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